RGNX Competitors & Alternatives
Compare Regenxbio Inc with similar stocks in the same industry
Biotechnology
RGNX
Main Stock$7.43
Tradestie Score
58
Market Cap
$493.52M
Revenue Growth
4.1%
Analyst Upside
+219.3%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$77.97
|
$522.78M | - | 57 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.82
|
$512.39M | - | 65 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$47.15
|
$505.12M | 2.9 | 57 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$96.99
|
$492.21M | - | 53 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 46 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$11.07
|
$468.01M | - | 38 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$10.50
|
$463.20M | - | 42 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$6.85
|
$457.09M | - | 55 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$7.90
|
$454.29M | - | 38 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 50 | Compare |
More RGNX Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2836)
228 stocks in this industry